All studies
Metabolism·October 16, 2026·5 min read

Thyroid Hormone Does Not Help Older Adults With Mildly Underactive Thyroid

In adults 65+ with TSH 4.60-19.99 and normal free T4, levothyroxine lowered TSH but showed no significant between-group difference in symptoms or fatigue in the TRUST trial.

Does levothyroxine help subclinical hypothyroidism in older adults?

No. In adults 65 and older with a mildly high TSH of 4.60 to 19.99 mIU/L and a normal free T4, levothyroxine lowers TSH but provides no apparent clinical benefit. The 2017 TRUST trial in the New England Journal of Medicine randomized 737 people with persisting subclinical hypothyroidism to levothyroxine or placebo. At one year, the treated group had a lower TSH but no significant difference in hypothyroid symptoms or fatigue scores.

What the trial actually showed

The trialists recruited adults at least 65 years old whose TSH stayed between 4.60 and 19.99 mIU/L and whose free T4 was normal. Mean age was 74.4 years, 53.7% were women, and mean baseline TSH was 6.40 mIU/L. People took levothyroxine or placebo. The trial lasted one year, and the abstract reports only the one-year outcome. That is long enough to see whether thyroid-related symptoms respond, because those symptoms change over weeks to months.

At one year, mean TSH was 5.48 mIU/L in the placebo group and 3.63 mIU/L in the levothyroxine group. So the drug did the chemical job it was supposed to do. It lowered TSH.

Mean TSH at baseline and one year in the TRUST trial
Baseline mean6.4mIU/L
Placebo5.48mIU/L
Levothyroxine3.63mIU/L

The clinical measurements showed no significant between-group difference at one year. Hypothyroid symptoms and fatigue improved similarly in both groups; the trial found no significant between-group difference at one year. The treated patients had a different TSH number and a similar experience.

What levothyroxine moved in adults 65+ with normal free T4
MeasurePlaceboLevothyroxine
TSH5.48 mIU/L3.63 mIU/L
Hypothyroid symptomsNo significant difference (per trial)No significant difference (per trial)
Fatigue scoreNo significant difference (per trial)No significant difference (per trial)

Scroll the table sideways for the rest →

At one year. Symptom and fatigue changes were not significantly different between groups (per trial).

A mildly high TSH only means something next to free T4, symptoms, and age.

On a graph, the TSH line falls and the symptom lines overlap. That gap is the whole finding. TSH is a lab value, not a symptom score.

Why a mildly high TSH means less after 65

TSH is not thyroid hormone. It is the pituitary signal to the thyroid. When free T4 drops, TSH normally rises to demand more production. In overt hypothyroidism, free T4 is low and the TSH rise makes sense as a disease marker.

In subclinical hypothyroidism, free T4 is still within the reference range. The thyroid is still producing hormone. The mildly high TSH is a regulator shouting a little louder, not a failing gland.

For older adults, the normal TSH distribution shifts upward. The American Thyroid Association 2014 hypothyroidism guidelines note that age-specific TSH reference ranges may be more appropriate, so a TSH of 5 or 6 can be closer to age-expected than it looks on a generic adult printout. The common mistake is to treat the TSH until it looks normal on a young adult range. Because a single mildly high TSH can be transient, the same guidelines recommend repeating the thyroid panel before diagnosing subclinical hypothyroidism.

That is why a high TSH alone cannot carry the decision. Free T4 matters. Age and symptoms matter as much. The hormone test and the clinical picture matter more than the regulatory signal in isolation.

What this looks like on your lab report

It usually looks like a red flag next to TSH and a normal free T4 a few lines below. The report might say high next to TSH, but the free T4 is sitting in the middle of the range. That pattern is not the same as an underactive thyroid.

One high TSH is a signal, not a sentence. The American Thyroid Association 2014 hypothyroidism guidelines recommend repeat testing before diagnosing subclinical hypothyroidism. If free T4 is normal on two draws, you are looking at a stable pattern, not an emergency. The first step is not to treat the red flag. It is to repeat the panel and see whether the TSH stays up. In this trial, the TSH had to be persisting before people were enrolled. A single draw is weaker than two draws.

If you upload a lab report to HealthOS Blood, it reads the full thyroid panel and explains the markers against ranges matched to your age and biological sex. A second upload shows how each marker moved.

When the simple answer does not hold

This trial does not apply to people with low free T4. Low free T4 with high TSH is overt hypothyroidism, a different state where thyroid hormone replacement is standard.

The result is also specific to adults 65 and older with TSH between 4.60 and 19.99 mIU/L. It does not answer what to do for a 35-year-old with symptoms, for pregnancy, for TSH above 20, or for anyone with a lump, pressure symptoms, or a clear downward trend in free T4. In those situations, the evidence thins out or points elsewhere, and a different conversation with a doctor is warranted.

What to check before treating a TSH number

  • Look at free T4 first. If free T4 is low, this study does not apply.
  • Repeat the thyroid panel. Guidelines recommend confirming persistence before treating subclinical hypothyroidism.
  • Treat the person, not the TSH. If you are 65 or older and your TSH is in the 4.60 to 19.99 mIU/L range with normal free T4, the trial found no significant symptom benefit from levothyroxine.
  • If symptoms are worsening, free T4 is falling, or TSH is outside that range, ask a doctor.

Levothyroxine is not a zero-risk placeholder, especially in older adults. The bar for treating a number should be higher than the bar for retesting it.

You can see this pattern in your own numbers at https://healthosx.com/blood. Upload a PDF or photo, and the free tool explains every thyroid marker against age and sex matched ranges. A second upload shows the trend.

Written by

HealthOS Research

Keep reading